TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 4 | -0 | 1 | -2 | 4 | 14 | 26 | 7 |
S | %wins | 100 | 50 | 75 | 50 | 0 | 0 | 46 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/14 16:18 | 8/8/14 | IART | Integra Lifesciences Holdings Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Larkin Brian | NJ | O | Corp VP, | S | -94 | 48.28 | 8 | -2 | -22 | 7 | D | 28 | 27 | 8 | 8 | 3 | 3 | 2 | -3 | -1 | -1 | 3 | -4 | 14 | 40 |
2/28/14 16:12 | 2/27/14 | IART | Integra Lifesciences Holdings Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Larkin Brian | NJ | O | Corp VP, | S | -151 | 46.15 | 7 | -3 | -24 | 10 | D | 48 | 16 | 12 | 1 | -5 | 3 | -3 | -2 | 0 | 3 | -4 | -3 | 6 | 28 |
8/20/13 16:04 | 8/19/13 | IART | Integra Lifesciences Holdings Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Larkin Brian | NJ | O | Corp VP, | S | -314 | 41.90 | 7 | -7 | -36 | 14 | D | 5 | 6 | -5 | 14 | 11 | 10 | 10 | 12 | 0 | -1 | -5 | 7 | 12 | 16 |
5/22/13 16:13 | 5/21/13 | IART | Integra Lifesciences Holdings Corp | DE | Electr | LabEq | Laboratory Analytical Instrum | Larkin Brian | NJ | O | Corp VP, | S | -7 | 36.86 | 9 | 0 | -1 | 21 | D | -27 | 9 | 1 | -12 | -4 | 7 | 4 | 2 | 0 | 2 | -1 | 15 | 22 | 21 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |